丙型肝炎的联合抗病毒治疗进展

金生; 张大志

丙型肝炎的联合抗病毒治疗进展

金生,
张大志

详细信息

中图分类号: R512.63
计量
- 文章访问数: 3143
- HTML全文浏览量: 3
- PDF下载量: 838
- 被引次数: 0
出版历程
- 出版日期: 2004-05-20

摘要

HTML全文

参考文献(17)

[1]WeeginkCJ, SentjensRE , BeldMG , etal.ChronichepatitisCpatientswithapost-treatmentvirologicalrelapsere-treatedwithaninductiondoseof18MUinterferon-alphaincombinationwithribavirinandaman tadine:atwo-armrandomizedpilotstudy[J].JViralHepat, 2003, 10∶174-182.

[2]Steindl-MundaP , FerenciP , BrnnerH , etal.Impactofhigh-doseinterferoninductionandribavirintherapyinpatientswithchronichepatitisCrelapsingafterornotrespondingtointerferonmonotherapy[J].LiverInt, 2003, 23∶269-275

[3]KotzevⅠ, IvanovaⅠ, AtanassovaM , etal.Highinitialdosecombina tionregimenwithinterferon-alphaandribavirininchronichepatitisC[J].Hepatogastroenterology, 2003, 50∶463-466.

[4]P啨ｒｅｚ-OlmedaM , N挷 ezM , RomeroM , etal.PegylatedIFN -al pha2bplusribavirinastherapyforchronichepatitisCinHIV -infectedpatients[J].AIDS , 2003, 17∶1023-1028.

[5]ButiM , MedinaM , CasadoMA , etal.Acost-effectivenessanalysisofpeginterferonalfa-2bplusribavirinforthetreatmentofnaivepatientswithchronichepatitis[J].AlimentPharmacolTher, 2003, 17∶687-694.

[6]PockrosPJ, ReindollarR , McHutchinsonJ, etal.Thesafetyandtolera bilityofdailyinfergenplusribavirininthetreatmentofna姫 vechronichepatitisCpatients[J].JViralHepat, 2003, 10∶55-60.

[7]FujiyamaS , ChikazawaH , HondaY , etal.EffectiveinterferontherapyforchronichepatitisCpatientswithlowviralloads[J].Hepatogas troenterology, 2003, 50∶817-820.

[8]JessnerW , StauberR , HacklF , etal.Earlyviralkineticsontreatmentwithpegylatedinterferon-alpha-2ainchronichepatitisCvirusgeno type1infection[J].JViralHepat, 2003, 10∶37-42.

[9]AraseY , IkedaK , TsubotaA , etal.EfficacyofprolongedinterferontherapyforpatientswithchronichepatitisCwithHCV -genotype1bandhighvirusload[J].JGastroenterol, 2003, 38∶158-163.

[10]HoriikeN , HinoH , TanakaY , etal.Combinationtherapywithinter feronalphaandbetatochronichepatitisC[J].OncolRep, 2003, 10∶157-161.

[11]FormannE , JessnerW , BennettL , etal.Twice-weeklyadministra tionofpeginterferon-alpha-2bimprovesviralkineticsinpatientswithchronichepatitisCgenotype1[J].JViralHepat, 2003, 10∶271-276.

[12]InoueK , SekiyamaK , YamadaM , etal.Combinedinterferonalpha2bandcyclosporinAinthetreatmentofchronichepatitisC :controlledtrial[J].JGastroenterol, 2003, 38∶567-572.

[13]CotlerSJ, MorrisseyMJ , WileyTE , etal.Apilotstudyofthecombi nationofcyclosporinAandinterferonalfacon-1forthetreatmentofhep atitisCinpreviousnonresponderpatients[J].JClinGastroenterol, 2003, 36∶352-355.

[14]BizollonT , AhmedSN , RadenneS , etal.Longtermhistologicalim provementandclearanceofintrahepatichepatitisCvirusRNAfollowingsustainedreponsetointerferon-ribavirincombinationtherapyinlivertransplantedpatientswithhepatitisCvirusrecurrence[J].Gut, 2003, 52∶283-287.

[15]HoofnagleJH , GhanyMG , KleinerDE , etal.MaintenancetherapywithribavirininpatientswithchronichepatitisCwhofailtorespondtocombinationtherapywithinterferonalfaandribavirin[J].Hepatology, 2003, 38∶66-74.

[16]ThuluvathPJ , PandeH , MaygersJ.Combinationtherapywithinterferon-alpha (2b) , ribavirin, andamantadineinchronichepatitisCnonre sponderstointerferonandribavirin[J].DigDisSci, 2003, 48∶594-597.

[17]YangSS , TuTC , WuCH , etal.Combinationofinterferonalfa-2aandamantadinedoesnotimprovetheefficacyofinterferontherapyinpa tientswithchronichepatitisC[J].Hepatogastroenterology, 2003, 50∶1575-1578.

施引文献

资源附件(0)

访问统计